Cargando…

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer

Human cell division cycle-related protein 8 (CDCA8) is an essential component of the vertebrate chromosomal passenger complex (CPC). CDCA8 was confirmed to play a role in promoting malignant tumor progression. However, the exact function of CDCA8 in the development and progression of prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Shun, He, Yang, Zhang, Bin, Yang, Zhi, Du, Fang-Ming, Zhang, Chun-Peng, Fu, Yu-Qiang, Mi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016845/ https://www.ncbi.nlm.nih.gov/pubmed/35449575 http://dx.doi.org/10.3389/fonc.2022.784183

Ejemplares similares

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Markers, Disease
Publicado: (2023)

CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma
por: Bai, Yuanyuan, et al.
Publicado: (2022)

Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors
por: Zhuang, Chun, et al.
Publicado: (2023)

CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
por: Zhang, Yixiang, et al.
Publicado: (2020)

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
por: Kuo, Yu-Hsuan, et al.
Publicado: (2021)

High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer
por: Li, Siman, et al.
Publicado: (2020)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer
por: Xue, Jingyan, et al.
Publicado: (2021)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer
por: Li, Yixuan, et al.
Publicado: (2021)

Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer
por: Gu, Peng, et al.
Publicado: (2022)

DDX39 Overexpression Predicts a Poor Prognosis and Promotes Aggressiveness of Melanoma by Cooperating With SNAIL
por: Xing, Chengjuan, et al.
Publicado: (2020)

Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients
por: Li, Xin, et al.
Publicado: (2021)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022)

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022)

Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells
por: Gao, Xin, et al.
Publicado: (2020)

CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints
por: Tang, Mengying, et al.
Publicado: (2022)

Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer
por: Wu, Mengjie, et al.
Publicado: (2020)

Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma via EMT
por: Na, Sijia, et al.
Publicado: (2022)

High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers
por: Zhang, Ling, et al.
Publicado: (2021)

The ncRNA-Mediated Overexpression of Ferroptosis-Related Gene EMC2 Correlates With Poor Prognosis and Tumor Immune Infiltration in Breast Cancer
por: Liu, Xing, et al.
Publicado: (2021)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

The Comprehensive Analysis Illustrates the Role of CDCA5 in Breast Cancer: An Effective Diagnosis and Prognosis Biomarker
por: Gao, Yang, et al.
Publicado: (2023)

High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
por: Wang, Yunhan, et al.
Publicado: (2023)

CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oji49ijt03egkpakfc402gnh8c